During the Pandemic, Telemedicine Follow-up for Heart Failure Improved 30-Day Outcomes
A study examined if early outpatient follow-up via telemedicine reduces 30-day readmission in patients with heart failure as effectively as in-person follow-up.
Heart Failure
Mavacamten Evaluated in Patients With Obstructive Hypertrophic Cardiomyopathy Eligible for SRT
The VALOR-HCM trial evaluated the effects of mavacamten in over 100 patients with symptomatic obstructive HCM (NYHA class III-IV) who met the guideline criteria for SRT and had been referred for an invasive procedure.
Is Heart Failure Linked to Increased Risk for Cancer and Cancer-Related Mortality?
Researchers examined the association between pre-existing heart failure and cancer incidence and mortality in a community-based cohort.
Omecamtiv Mecarbil Under Review for Heart Failure With Reduced Ejection Fraction
The NDA is supported by data from the phase 3 GALACTIC-HF trial which included 8256 adults with heart failure with reduced ejection fraction,
SGLT2 Inhibitors Underprescribed for Chronic Kidney Disease
Affordability of SGLT2i may contribute to the low prescription rate in CKD.
Aficamten Gets Breakthrough Tx Status for Obstructive Hypertrophic Cardiomyopathy
The designation was based on data from the phase 2 REDWOOD-HCM trial.
Empagliflozin Gets Priority Review for Heart Failure Independent of LVEF
The application is supported by data from the phase 3 EMPEROR-Preserved trial.
Gender, Socioeconomic Factors May Affect QOL With Cardiac Devices
Researchers examined the effect of implantable cardiac assistive devices on patients’ quality of life.
CaroSpir, a Liquid Form of Spironolactone, Now Available in Unit Dose Cups
The new packaging allows for ease of administration and convenience.
Sex-Based Differences in Heart Failure Frailty Explored
This study sought to characterize sex differences in heart failure physical frailty phenotypes.
- Loading...
Loading...
Next post in News
Loading... 
Loading...